Efficacy and Safety of Different Doses of Rituximab Therapy in Pemphigus Patients

Clinical trial NCT07457944 · COMPLETED

Trial details

NCT number: NCT07457944
Sponsor: Ruijin Hospital
Status: COMPLETED
Study type: OBSERVATIONAL

Pemphigus Disease Rituximab (RTx)

Start date: 2019-01-01
Primary completion: 2023-01-01
Enrollment: 275

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.